A carregar...
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
BACKGROUND: Tumor mesothelin overexpression is present in different malignancies, including the majority of patients with pancreatic or biliary cancers. The objective of this study was to evaluate the use of shed serum mesothelin and megakaryocyte potentiating factor (MPF) concentrations as biomarke...
Na minha lista:
| Publicado no: | Clin Chem Lab Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309905/ https://ncbi.nlm.nih.gov/pubmed/22149739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/CCLM.2011.816 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|